Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) just unveiled an update.
WuXi AppTec Co., Ltd. announced its annual results for the year ended December 31, 2024, including a proposed final cash dividend of RMB 9.8169 per 10 shares, subject to shareholder approval at the upcoming AGM. The total dividend amounting to RMB 2,835,113,437.82 is expected to be distributed by June 30, 2025, reflecting the company’s commitment to returning value to its shareholders.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. operates in the pharmaceutical and biotechnology industry, providing a wide range of services including drug discovery, development, and manufacturing. The company focuses on offering comprehensive solutions to pharmaceutical and healthcare companies globally.
YTD Price Performance: 14.16%
Average Trading Volume: 5,403,051
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$194.8B
Learn more about 2359 stock on TipRanks’ Stock Analysis page.